Chondrosarcoma Journal Article


Authors: Healey, J. H.; Lane, J. M.
Article Title: Chondrosarcoma
Abstract: Chondrosarcoma is a malignant cartilage-forming tumor that affects predominently the middle-aged population. There are three histologic grades, but differentiation of Grade I tumors from enchondromas can be difficult. The measurement of polypoidy (augmented chromosomal content per cell) appears to offer a method of segregation of benign from low-grade from high-grade tumors. With the exception of the high-grade spindle elements, current chemotherapy does not appear to affect chondrosarcomas. Retinoic acid, however, by enhancing lysosomal enzyme release, may be a potential efficacious therapeutic agent. Enhanced tumor staging as provided by the computed tomographic (CT) scan has demonstrated the boundaries for wide surgical excisions, most notably internal hemipelvectomies for low- and moderate-grade pelvic chondrosarcomas. Currently, low-grade chondrosarcomas have an overall five-year survival of 65%-85% in contradistinction to 15% for the highest grade chondrosarcomas.
Keywords: major clinical study; cancer staging; computer assisted tomography; diagnosis; bone; chondrosarcoma; retinoic acid; therapy; computer analysis; human; priority journal
Journal Title: Clinical Orthopaedics and Related Research
Volume: 204
ISSN: 0009-921X
Publisher: Springer  
Date Published: 1986-03-01
Start Page: 119
End Page: 129
Language: English
DOI: 10.1097/00003086-198603000-00012
PUBMED: 3956003
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 18 August 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. John H Healey
    551 Healey
  2. Joseph M. Lane
    66 Lane
Related MSK Work